Jefferies raised its price target on Insulet Corporation (NASDAQ: PODD) to $58.00 (from $48.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst PT Change

Insulet Corporation (PODD) PT Raised to $63 at Cowen on 2Q Report; 'Direct Europe Commercialization Drives Sharp Upward Estimate Revisions'August 4, 2017 6:42 AM Insulet (PODD) Reports In-Line Q2 EPS, FY Revenue Guidance BeatsAugust 3, 2017 5:45 PM Insulet Reports Second Quarter 2017 Financial ResultsAugust 3, 2017 4:01 PM Insulet’s Programs at the American Association of Diabetes Educators Conference and Its New San Diego Innovation Center of Excellence Highlight Company’s Commitment to InnovationAugust 2, 2017 4:30 PM